Transgene Biotek (BOM:526139) Net Issuance of Preferred Stock : ₹0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2001. Start your Free Trial

What is Transgene Biotek Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Transgene Biotek's net issuance of preferred for the three months ended in Mar. 2025 was ₹0.00 Mil. The number is 0, which means that Transgene Biotek has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Transgene Biotek's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.00 Mil.

Transgene Biotek Net Issuance of Preferred Stock Historical Data

The historical data trend for Transgene Biotek's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transgene Biotek Net Issuance of Preferred Stock Chart

Transgene Biotek Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Transgene Biotek Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Transgene Biotek Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

Transgene Biotek Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Transgene Biotek's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Transgene Biotek Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgene Biotek Ltd (BOM:526139) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Anrich Industrial Area, Plot No. 69 and 70, IDA Bollaram, Sangareddy District, Medak, TG, IND, 502325

Website

https://www.transgenebiotek.com

Transgene Biotek Ltd is an India-based research and development company. It is engaged in the research and development of molecules and technologies for the production of active pharmaceutical ingredients and other pharmaceutical products. The company is operating only in one segment of Bulk Drugs. Its product portfolio includes TrabiDHA, Tracolimus, and Orlistat. It generates revenue from the sale of goods and services.

Transgene Biotek Headlines

No Headlines